Efficacy of alendronate in the treatment of the SAPHO syndrome

J Clin Rheumatol. 2008 Jun;14(3):183-4. doi: 10.1097/RHU.0b013e318177a64f.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acquired Hyperostosis Syndrome / drug therapy*
  • Adult
  • Alendronate / therapeutic use*
  • Bone Density Conservation Agents / therapeutic use*
  • Female
  • Humans

Substances

  • Bone Density Conservation Agents
  • Alendronate